Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-06-002401
Filing Date
2006-03-16
Accepted
2006-03-16 16:23:18
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANDRX CORPORATION g00140e10vk.htm 10-K 1302456
2 DISTRIBUTION AGREEMENT g00140exv10w102.htm EX-10.102 168599
3 SUPPLY AGREEMENT g00140exv10w109.htm EX-10.109 121498
4 SUBSIDIARIES OF ANDRX g00140exv21w1.htm EX-21.1 2123
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM g00140exv23w1.htm EX-23.1 1672
6 SECTION 302 CEO CERTIFICATION g00140exv31w1.htm EX-31.1 8079
7 SECTION 302 CFO CERTIFICATION g00140exv31w2.htm EX-31.2 8370
8 SECTION 906 CEO AND CFO CERTIFICATION g00140exv32.htm EX-32 4046
  Complete submission text file 0000950144-06-002401.txt   1618244
Mailing Address 4001 SOUTHWEST 47TH AVE STE 201 FT LAUDERDALE FL 33314
Business Address 4955 ORANGE DRIVE DAVIE FL 33314 9545840300
ANDRX CORP /DE/ (Filer) CIK: 0001123337 (see all company filings)

EIN.: 651013859 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31475 | Film No.: 06692269
SIC: 2834 Pharmaceutical Preparations